Style | Citing Format |
---|---|
MLA | Kazemi A, et al.. "Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations." Critical Reviews in Food Science and Nutrition, vol. 65, no. 8, 2025, pp. 1553-1578. |
APA | Kazemi A, Iraji A, Esmaealzadeh N, Salehi M, Hashempur MH (2025). Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations. Critical Reviews in Food Science and Nutrition, 65(8), 1553-1578. |
Chicago | Kazemi A, Iraji A, Esmaealzadeh N, Salehi M, Hashempur MH. "Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations." Critical Reviews in Food Science and Nutrition 65, no. 8 (2025): 1553-1578. |
Harvard | Kazemi A et al. (2025) 'Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations', Critical Reviews in Food Science and Nutrition, 65(8), pp. 1553-1578. |
Vancouver | Kazemi A, Iraji A, Esmaealzadeh N, Salehi M, Hashempur MH. Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations. Critical Reviews in Food Science and Nutrition. 2025;65(8):1553-1578. |
BibTex | @article{ author = {Kazemi A and Iraji A and Esmaealzadeh N and Salehi M and Hashempur MH}, title = {Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations}, journal = {Critical Reviews in Food Science and Nutrition}, volume = {65}, number = {8}, pages = {1553-1578}, year = {2025} } |
RIS | TY - JOUR AU - Kazemi A AU - Iraji A AU - Esmaealzadeh N AU - Salehi M AU - Hashempur MH TI - Peppermint and Menthol: A Review on Their Biochemistry, Pharmacological Activities, Clinical Applications, and Safety Considerations JO - Critical Reviews in Food Science and Nutrition VL - 65 IS - 8 SP - 1553 EP - 1578 PY - 2025 ER - |